This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

West Pharmaceutical Services Inc (WST)

NYSE: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 230.00M 161.90M 91.80M 110.20M
Receivables 185.70M 175.00M 147.20M 126.40M
Inventories 176.90M 162.20M 151.80M 147.00M
Other Current Assets 34.70M 38.10M 73.30M 42.50M
Total Current Assets 650.70M 557.30M 472.00M 436.60M
Property, Plant & Equipment, Gross 1.37B 1.27B 1.14B 1.08B
Accumulated Depreciation & Depletion 657.30M 605.80M 543.20M 522.40M
Property, Plant & Equipment, Net 711.70M 669.00M 593.60M 554.80M
Intangibles 48.30M 50.60M 52.00M 55.10M
Other Non-Current Assets 84.90M 84.30M 84.90M 70.80M
Total Non-Current Assets 1.02B 1.01B 927.10M 857.70M
Liabilities & Shareholder Equity
Total Assets 1.67B 1.56B 1.40B 1.29B
Accounts Payable 108.00M 102.90M 89.80M 63.20M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 65.40M 66.90M 56.00M 57.90M
Total Current Liabilities 236.90M 261.80M 243.20M 169.70M
Long Term Debt 371.30M 378.80M 299.30M 358.10M
Deferred Income Taxes 18.90M 20.80M 21.60M 20.00M
Other Non-Current Liabilities 138.10M 173.70M 180.10M 120.80M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 528.30M 573.30M 501.00M 498.90M
Total Liabilities 765.20M 835.10M 744.20M 668.60M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 906.40M 728.90M 654.90M 625.70M
Common Par 17.60M 8.60M 8.60M 8.60M
Additional Paid In Capital 120.00M 79.30M 76.30M 77.30M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 805.00M 719.90M 664.50M 612.60M
Treasury Stock -3.80M -3.00M -23.00M -41.50M
Other Equity Adjustments -32.40M -75.90M -71.50M -31.30M
Total Capitalization 1.28B 1.11B 954.20M 983.80M
Total Equity 906.40M 728.90M 654.90M 625.70M
Total Liabilities & Stock Equity 1.67B 1.56B 1.40B 1.29B
Total Common Shares Outstanding 70.20M 68.60M 67.40M 66.60M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 200.00K 400.00K 2.40M 4.00M
Basic Weighted Shares Outstanding 69.60M 68.00M 67.40M 66.60M
Diluted Weighted Shares Outstanding 71.40M 71.80M 74.00M 73.40M
Number of Employees 6900 6700 6300 6600
Number of Part-Time Employees 0 0 0 0
WST News

WST West Pharmaceutical Services Inc

Analysts Ratings for WST

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

WST Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs